BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8826869)

  • 1. Recurrences and related characteristics of gastric cancer.
    Maehara Y; Emi Y; Baba H; Adachi Y; Akazawa K; Ichiyoshi Y; Sugimachi K
    Br J Cancer; 1996 Sep; 74(6):975-9. PubMed ID: 8826869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern and risk factors of recurrence of proximal gastric cancer after curative resection.
    Li F; Zhang R; Liang H; Liu H; Quan J
    J Surg Oncol; 2013 Feb; 107(2):130-5. PubMed ID: 22949400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer.
    Maehara Y; Hasuda S; Koga T; Tokunaga E; Kakeji Y; Sugimachi K
    Br J Surg; 2000 Mar; 87(3):353-7. PubMed ID: 10718807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer.
    Maehara Y; Kabashima A; Tokunaga E; Hasuda S; Oki E; Kakeji Y; Baba H; Sugimachi K
    Oncology; 1999; 56(4):322-7. PubMed ID: 10343197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer.
    Maehara Y; Tomisaki S; Oda S; Kakeji Y; Tsujitani S; Ichiyoshi Y; Akazawa K; Sugimachi K
    Int J Cancer; 1997 Apr; 74(2):224-8. PubMed ID: 9133460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer.
    Maehara Y; Kakeji Y; Oda S; Takahashi I; Akazawa K; Sugimachi K
    Br J Cancer; 2000 Oct; 83(8):986-91. PubMed ID: 10993643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer.
    Maehara Y; Oshiro T; Baba H; Ohno S; Kohnoe S; Sugimachi K
    Surgery; 1995 Apr; 117(4):380-5. PubMed ID: 7716718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
    Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
    Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tumor cell proliferation and intratumor microvessel density in advanced gastric cancer treated with curative surgery.
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Hara H; Sako S; Nishiguchi K; Ohtani M; Tenjo T; Nohara T; Tanigawa N
    Int J Oncol; 1998 Aug; 13(2):255-9. PubMed ID: 9664119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
    Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
    Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Survival in Node-Negative Gastric Cancer Patients Who Underwent Curative Resection.
    Zhou Y; Cui JG; Huang F; Zhang A; Li C; Zhao ZC; Li WD; Fu WH
    Scand J Surg; 2017 Sep; 106(3):235-240. PubMed ID: 28376652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.